Abstract
Aim
To develop a robust assay to evaluate and compare the intravitreal mobility of nanoparticles in the intact vitreous body.Materials & methods
Excised bovine eyes were prepared to preserve the fragile structure of the vitreous humor, while permitting high-resolution fluorescence microscopy and single-particle tracking analysis of intravitreally injected nanoparticles. This assay was validated by analyzing polystyrene beads and further employed to evaluate gene nanomedicines composed of poly(amido amine)s and plasmid DNA.Results
The assay was able to distinguish immobilized cationic nanoparticles from mobile PEGylated nanoparticles. PEGylation of the polyplexes resulted in a drastic improvement of their mobility.Conclusion
An ex vivo eye model is presented for studying nanoparticle mobility in intact vitreous humor by single-particle tracking microscopy. These results give important guidelines for developing gene- and drug-delivery nanomedicines that are compatible with intravitreal administration.References
Articles referenced by this article (61)
A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes.
Mol Vis, 116-124 2000
MED: 10889272
Ocular gene therapy: current progress and future prospects.
Trends Mol Med, (1):23-31 2008
MED: 19097940
Leber congenital amaurosis: genes, proteins and disease mechanisms.
Prog Retin Eye Res, (4):391-419 2008
MED: 18632300
Gene transfer for neovascular age-related macular degeneration.
Hum Gene Ther, (5):523-529 2011
MED: 21443427
Republished review: Gene therapy for ocular diseases.
Postgrad Med J, (1029):487-495 2011
MED: 21705775
DNA-based therapeutics and DNA delivery systems: a comprehensive review.
AAPS J, (1):E61-77 2005
MED: 16146351
Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Drug Discov Today, (3-4):135-143 2008
MED: 18275911
Title not supplied
Show 10 more references (10 of 61)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.2217/nnm.12.202
Article citations
Mathematical Models of Ocular Drug Delivery.
Invest Ophthalmol Vis Sci, 65(11):28, 01 Sep 2024
Cited by: 0 articles | PMID: 39287588 | PMCID: PMC11412384
Review Free full text in Europe PMC
Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases.
Transl Vis Sci Technol, 13(6):17, 01 Jun 2024
Cited by: 0 articles | PMID: 38913008 | PMCID: PMC11205237
Progress in Ocular Drug Delivery: Challenges and Constraints.
Handb Exp Pharmacol, 284:267-288, 01 Jan 2024
Cited by: 0 articles | PMID: 37620616
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment.
Drug Deliv, 30(1):2204206, 01 Dec 2023
Cited by: 4 articles | PMID: 37194147 | PMCID: PMC10193918
Review Free full text in Europe PMC
Correlation of Aqueous, Vitreous, and Serum Protein Levels in Patients With Retinal Diseases.
Transl Vis Sci Technol, 12(11):9, 01 Nov 2023
Cited by: 4 articles | PMID: 37930665 | PMCID: PMC10629536
Go to all (35) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
J Control Release, 202:83-92, 26 Jan 2015
Cited by: 58 articles | PMID: 25634806
Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Eur J Pharm Sci, 103:27-35, 20 Feb 2017
Cited by: 13 articles | PMID: 28223236
The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.
Biomaterials, 33(12):3485-3493, 07 Feb 2012
Cited by: 77 articles | PMID: 22322197
Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer.
J Control Release, 122(3):226-235, 13 May 2007
Cited by: 28 articles | PMID: 17574287
Review